Company continues to expand its Near Surface High-Grade Copper, Platinum, Palladium, Gold and Silver Zone 5km Northeast of its Main Nisk Deposit TORONTO, June 4, 2024 /PRNewswire/ – Power Nickel Inc. (the “Company” or “Power Nickel”) (TSXV: PNPN) is pleased to announce high-grade…
Month: June 2024
GENEVA, June 4, 2024 /PRNewswire/ — Following successful completion of Beta testing Dukascopy Bank SA proudly announces the inclusion of MetaTrader 5 (MT5) to our suite of trading platforms, including the outstanding JForex 4 and the popular MT4 platform. This addition marks a…
STOCKHOLM, June 4, 2024 /PRNewswire/ — Autoliv China, a division of Autoliv, Inc. (NYSE: ALV) (SSE: ALIV-SDB), the worldwide leader in automotive safety systems, and XPENG AEROHT, Asia’s leading flying car innovator, have signed a strategic cooperation agreement to pioneer safety…
SINGAPORE, June 4, 2024 /PRNewswire/ — AgentLayer, a leading Ethereum Layer 2 blockchain and AI integration innovation platform, announced that its AgentLayer Premium Governance Node (APGN) sold 2000 nodes within one day of going on sale, with a total value of $1,600,000, setting a new…
OSLO, Norway, June 4, 2024 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announces that it has commenced activities to support a new initiative enabling U.S. Hospitals and Clinics to offer blue light cystoscopy (BLC®) using a mobile capital equipment model….
OSLO, Norway, June 4, 2024 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announces that it has commenced activities to support a new initiative enabling U.S. Hospitals and Clinics to offer blue light cystoscopy (BLC®) using a mobile capital equipment model….
STOCKHOLM, June 4, 2024 /PRNewswire/ — CheckProof, a Swedish SaaS company, is thrilled to announce a significant investment and long-term partnership with Viking Venture, the leading Nordic B2B software investor. CheckProof provides a user-friendly, all-in-one platform for the…
ADESOS Phase 2b study evaluating orismilast as an oral treatment in 233 patients with moderate-to-severe atopic dermatitis (AD) has successfully completed Results from the ADESOS study have been selected for an oral presentation at the late breaking research sessions at the RAVE…
ADESOS Phase 2b study evaluating orismilast as an oral treatment in 233 patients with moderate-to-severe atopic dermatitis (AD) has successfully completed Results from the ADESOS study have been selected for an oral presentation at the late breaking research sessions at the RAVE…
SINGAPORE, June 4, 2024 /PRNewswire/ — Alchemy Pay, a leading fiat-crypto payment solution, has extended support to Celo, a mobile-first and EVM-compatible blockchain network fast becoming the ecosystem of choice for stablecoins and real-world asset (RWA) use cases, based on the previous…